Top Markets
Coin of the day
LumiraDx Limited LumiraDx Limited

LumiraDx Limited

LMDX
Rang in Aktien #34692
LumiraDx Limited is a prominent provider of point-of-care diagnostic solutions.... LumiraDx Limited is a prominent provider of point-of-care diagnostic solutions. Its core mission is to revolutionize community healthcare by equipping medical professionals with crucial diagnostic insights directly at the patient's side. The company develops and commercializes a sophisticated diagnostic platform, offering a diverse array of tests that deliver laboratory-grade performance directly at the point of care. With approximately 30 tests either commercially available or under development, their comprehensive portfolio addresses critical conditions such as infectious diseases, cardiovascular disorders, diabetes, and coagulation issues. Furthermore, they offer a full suite of COVID-19 testing solutions, adaptable for both laboratory environments and immediate point-of-need applications. These diagnostic tools are widely adopted by governments and healthcare institutions, deployed in diverse settings including traditional laboratories, urgent care clinics, physician's offices, pharmacies, schools, and workplaces. Their applications span screening, diagnosis, and monitoring for both general wellness and specific diseases. Established in 2014, the company's headquarters are located in London, United Kingdom.
Aktienkurs
$0.016
Zuletzt synchronisiert: 2025-06-17
Marktkapitalisierung
$5.10M
Veränderung (1 Tag)
0.00%
Veränderung (1 Jahr)
0.00%
Land
GB
Handel LumiraDx Limited (LMDX)

Kategorie

Kursverlauf für LumiraDx Limited (LMDX)
Höchster Schlusskurs: $0.02 am 2025-06-01

Niedrigster Schlusskurs: $9.67 am 2021-03-01
Kursverlauf der Aktie von LumiraDx Limited von 2021 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2025 7.14%
2024 -84.06%
2023 -90.77%
2022 -88.90%
2021 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
$588.21 20.29%
US
$202.45 -4.02%
US
$23.08 69.46%
CN
$309.93 90.12%
US
$551.60 -15.25%
US